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INTRODUCTION 
 
Pneumonia remains one of the most actual problems for a practicing physician. 
Important pathogenic significance in the development of pneumonia has already 
existing structural and functional changes in the lungs, and in particular chronic 
obstructive pulmonary disease (COPD).    
 
Development of pneumonia in patients with COPD can lead to a worsening of the 
prognosis and an increase in mortality in such patients. 
 
 
The mayo clinic defines copd as, ‘Chronic Obstructive Pulmonary Disease (COPD) is a chronic 
inflammatory lung disease that causes obstructed airflow from the lungs  
characterized by breathing difficulty, cough, mucus (sputum) 
production and wheezing.  
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OBJECTIVE 
This clinical case show the features of pneumonia on the background of chronic obstructive 
pulmonary disease.  
CLASSIFICATION OF СOPD 1 
GOLD 1 Mild FEV1 >=80% predicted 
GOLD 2 moderate 50-79% <FEV1 80% 
predicted 
GOLD 3 Severe 30-49% <FEV1 50% 
predicted 
GOLD 4 very severe 30% < FEV1 
30%predicteds 
CLASSIFICATION OF СOPD 2 
RISK FACTORS FOR PNEUMONIA 
Immunocompromised State 
Nosocomial Infection 
Chronic Alcoholism 
Smoking  
COPD 
Chronic Liver Disease 
Chronic Renal Failure 
 
OUR PATIENT 
Name: M.A.P. 
 
Age: 48 years 
 
Occupation: Engineer 
 
Location: Kharkiv 
 
Date of admission: 01.11.2018 
PRESENT COMPLAINTS  
 
 
Dry, persistent cough, moderate intensity, more often appears in the morning. 
 
Running nose, both nostrils will be blocked with mucus, whitish to yellow in color 
 
Headache around the eyes (frontal) and spreading to the occipital region, often last for 4 days, 
aching character, no relieving factors. 
 
Fever (37.5C) 
 
Difficulty in breathing 
 
Chest pain; which radiates to the right shoulder. More often early in the morning and after 
strenuous exercises. 
OBJECTIVE STATUS 1 
 
General condition: moderate, conciseness – clear. 
Temperature: 37.5C, Weight: 60 kg Height:165 cm 
BMI: 22 kg/m2 
Constitutional body type: Normosthenic 
Skin: pale, clean, well hydrated, tightened with reduced turgor. 
Thyroid gland: not palpable. 
Musculoskeletal system: limit movement in joints of knee, joints –elbow, clubbing of the 
fingers. 
OBJECTIVE STATUS 2 
Lungs: resonance percussion sound, hash breathing , decreased vesicular breathing and 
wheezing in inferior parts of both sides of lungs, RR -28cpm. 
Heart borders are not enlarged, heart tones are clear, loud, rhythmic; 
BP - 140\90 on both arms, radial pulse is synchronous, rhythmic at 96 bpm. 
Liver at the costal margin, painless; spleen is not palpable.  
sPasternatskiy sign - negative on both sides. Urination is free, painless. 
ANAMNESIS MORBI  
Patient notes recurrence of obstructive bronchitis for the past 2 years.  
He had visited the hospital for 4 consecutive occasions within the past one year.  
Consequently, with a diagnosis of chronic bronchitis he was seen by a pulmonologist, during 
exacerbations . 
 
Treatment was done at the hospital with mucolytics, antibiotics and glucocorticoids and 
salbutamol for inhalation. Lisinopril 10 mg 1tab dly  X 60 days  
Salbutamol 1pufff/ dly. 
 
3 days prior to his admission, suffered a sore throat, running nose, cough and fever till 38,5 C 
for 3 days. 
ANAMNESIS MORBI 
He was admitted to day hospital of polyclinic 24 for diagnosis : Chronic obstructive 
pulmonary disease 
(COPD).  
Chronic bronchitis in remission. 
 
ANAMNESIS VITAE 
Patient is a smoker since 16 years smoked about 3 packs of cigarettes a days, after 2002 he 
decreased amount of cigarettes to 1 pack per day ((16*60)/20= 48 pack/years! – very high 
risk for development of COPD.  
Infections, injuries, tuberculosis, sexually transmitted diseases were denied. 
Hereditary diseases are not identified. 
Allergological history was not identified. 
He takes at least 2 cups of strong coffee a day. 
His father was a known asthmatic. 
INVESTIGATIONS DATA 
СBC (01/11/2018) 
OPTION RESULTS NR 
Hemoglobin 172 130,0 – 160,0 g/L 
Erythrocytes 5,2 4,05 – 5,15 
 
 1012/L 
Color index 0,99 0,85 – 1,15 
Leukocytes 12,4 4,0 – 9,0 
 
 109/L 
ESR 20 2-15mm/h 
Stab neutrophils 1 1-6 % 
Segmented neutrophils 64 47-72% 
Eosinophils 6 0,5-5,0% 
Basophils - 1-1,0 % 
Lymphocytes 24 19-37% 
Monocytes 5 3-11 % 
Mild airflow obstruction FEV1 – 55,3% 
• moderate 
 
Airflow obstruction as FEV1/FVC – 
61.8%;  • severe airflow obstruction.  
   SPIROMETRY (15/07/18) 
Flattening of the diaphragm is often a more reliable 
feature of lung hyper expansion. 
 Airspace opacity, lobar consolidation, or interstitial 
opacities. 
The lungs are hyper-expanded that the inferior 
border of the heart becomes visible,  
the heart appears to float above the diaphragm 
(02/11/18) 
MANAGEMENT 
NON-PHARMACOLOGICAL 
APPROACH 
oRecommendations STOP 
SMOKING!!!!   
oTo maintain healthy lifestyle decrease 
sodium intake 
o lipid lowering diet  
oReduce aerobic non strenuous exercises 
 
 
 
 
PHARMACOLOGICAL APPROACH 
PNEUMONIA 
oCeftriaxone 2g IV 12-24hr for 5 days 
oAmbroxol Hydrochloride 30 mg 3times dly X 
7days 
COPD 
oDexamethazone 16mg / day x 2 days 
oEuphiline 125 mg/dly X 30 days 
oOxymethazoline 2-3 sprays every 10-12hours 
oTiotropium 18 mcg 1/dly 
oSalbutamol 100 mcg 3-4x  
oLisinopril 10 mg in the morning 
oAspirin 75mg once daily continuously 
 
DIAGNOSIS 
COPD, II stage, moderate degree according to the patient’s spirometry, FEV1 – 55,3% 
from predictive value, FEV1/FVC – 61.8% which represent GOLD 3(Severe). 
Community-acquired right-sided focal pneumonia of the inferior lobe.  
Sinusitis 
Arterial hypertension 
Secondary erythrocythemia (Due to chronic hypo oxygenation) 
 CONCLUSION  
 Pneumonia in patients with COPD aggravates the course of the underlying 
disease; at the same time, the presence of structural changes of lungs in COPD patients affects 
the state and prognosis of patients with pneumonia. 
 
Exacerbation of COPD is crucial events in its management because they negatively affect the 
health status, rates of hospitalization readmission and the disease progress.  
 
 In this regard, general practitioners should use accurate approach to this category of patients. 
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